A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters

I García, M del Carmen Conejo, A Ojeda… - Journal of …, 2010 - Elsevier
The activity of daptomycin compared to vancomycin against Staphylococcus epidermidis-
biofilms on intravascular catheters has been evaluated using the new Sevilla device that …

[HTML][HTML] Effect of daptomycin and vancomycin on Staphylococcus epidermidis biofilms: An in vitro assessment using fluorescence in situ hybridization

S Sutrave, J Kikhney, J Schmidt, A Petrich… - PLoS …, 2019 - journals.plos.org
Colonization of in-dwelling catheters by microbial biofilms is a major concern in patient
health eventually leading to catheter-related blood stream infections. Biofilms are less …

Comparison of the antibiotic activities of daptomycin, vancomycin, and the investigational fluoroquinolone delafloxacin against biofilms from Staphylococcus aureus …

W Siala, MP Mingeot-Leclercq… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Biofilm-related infections remain a scourge. In an in vitro model of biofilms using
Staphylococcus aureus reference strains, delafloxacin and daptomycin were found to be the …

[PDF][PDF] Development of an in Vitro Novel Device that Simulates the Real Life of the Biofilm Formation on Catheters under both Static and Continuous Fluid Flow …

M El-Azizi - American Journal of Microbiological Research, 2015 - researchgate.net
Biofilm model systems are essential to explore the development and the nature of the
microbial community within the biofilm as well as the mechanism of their resistance. The aim …

In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model

KL LaPlante, LA Mermel - Nephrology Dialysis Transplantation, 2007 - academic.oup.com
Background. Catheter lock solutions are used for prevention and management of catheter-
related bloodstream infections. We investigated the activity of daptomycin and vancomycin …

In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains …

D Lebeaux, V Leflon-Guibout, JM Ghigo… - Journal of …, 2015 - academic.oup.com
Objectives Treatment of catheter-related bloodstream infections (CRBSI) is hampered by the
characteristic tolerance of bacterial biofilms towards antibiotics. Our objective was to study …

[引用][C] Activity of antimicrobial agents against Staphylococcus epidermidis in established biofilms on latex catheter material and on titanium

D Taylor, B Prosser, R Cleeland - Journal of Antimicrobial …, 1988 - academic.oup.com
Sir, Once bacteria have gained a foothold by adherence, the cells become enveloped in a
matrix of hydrated exopolysaccharide, termed a glycocalyx (Costerton, Irvin & Cheng, 1981) …

[HTML][HTML] Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis …

AD Hall Snyder, C Vidaillac, W Rose… - Infectious diseases and …, 2015 - Springer
Introduction Medical device infections are associated with significant morbidity and mortality.
These difficult-to-treat infections often result in antibiotic failure and resistance. Combination …

Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus …

J Parra-Ruiz, C Vidaillac, WE Rose… - Antimicrobial agents and …, 2010 - Am Soc Microbiol
Biofilm formation is an important virulence factor that allows bacteria to resist host responses
and antibacterial agents. The aim of the study was to assess the in vitro activities of several …

Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis

A Pascual, ER de Arellano, LM Martinez… - Journal of Hospital …, 1993 - Elsevier
The effect of two polyurethane [“Cavafix Certo”(CAV);'Viacath'(VIA)] catheters on the in-vitro
activity of amikacin (AN), clindamycin (CM), cloxacillin (CX), ciprofloxacin (CIP), vancomycin …